Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318) - Image 1

£107.73

Springer Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318)

Name: Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318)
Brand: Springer
Price: 107.32 GBP
Availability: InStock

Immunology

Price History & Forecast

Last 67 days • 67 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 67 days • 1 price levels

Days at Price

Price Analysis

Most common price: £107 (67 days, 100.0%)

Price range: £107 - £107

Price levels: 1 different prices over 67 days

Description

Product Description Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people in the United States. With their novel, multifaceted approach to basic science, the authors of this book offer help to clinicians and hope to patients. From the Back Cover "There is a need for a paradigm shift in our thinking about the pathogenesis of multiple sclerosis." Challenging Charcot’s hypothesis that inflammatory response is the primary contributor to demyelination, Dr. Rodriguez and colleagues take a fresh, bold look at the causes and possible treatments of MS. Assuming oligodendrocyte injury as a prerequisite to MS, the authors explore viruses, toxins and genetic defects as possible culprits. They present novel methods to interrupt and reverse demyelination. This book examines the correlation between axonal loss and clinical deficits, including the implied role of the CD8+ T cell and perforin. It assesses proteases, specifically, kallikrein 6, which are strongly associated with active demyelination. By directing natural autoantibodies against oligodendrocytes that demonstrate remyelination in animal models, the authors envision clinical trials for remyelination enhancement. As internationally recognized specialists in a wide range of MS disciplines, the authors explore genetic tools for identifying patients who are most likely to experience spontaneous remyelination. Epidemiology studies offer additional avenues of treatment. Examples include uric acid, statin drugs, estrogen and progesterone. MS affects nearly 400,000 people in the United States, many of whom are between18 and 40 years of age. With their novel, multifaceted approach to basic science―and their applications in understanding cause and treatment―the authors offer help to clinicians and hope to patients.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3642437834
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Immunology
Domain: Amazon UK
Publication Date: 25 September 2014
Listed Since: 25 September 2014

Barcode

No barcode data available

Springer Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Multiple Sclerosis: Etiology, Diagnosis, and New Treatment Strategies (Current Clinical Neurology)

Myelin Repair and Neuroprotection in Multiple Sclerosis

Emerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments: 26 (Current Topics in Behavioral Neurosciences)

Mechanisms of Disease Pathogenesis in Multiple Sclerosis

Multiple Sclerosis Therapeutics

Multiple Sclerosis and CNS Inflammatory Disorders (NIP- Neurology in Practice)

Multiple Sclerosis: Clinician's Guide To Diagnosis And Treatment (Oxford American Neurology Library)

Neuroimaging in Multiple Sclerosis (Neurology-laboratory and Clinical Research Developments)

Multiple Sclerosis: A Mechanistic View

Springer - Myelin Repair and Neuroprotection in MS Book

Multiple Sclerosis: Causes, Diagnosis & Management (Immunology and Immune System Disorders)

Neuroimmunology: Multiple Sclerosis, Autoimmune Neurology and Related Diseases

Neuroimmunology: Multiple Sclerosis, Autoimmune Neurology and Related Diseases

Multiple Sclerosis: Methods and Protocols: 1304 (Methods in Molecular Biology, 1304)

Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology)

Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology)

Neurologic Disease: A Modern Pathophysiologic Approach to Diagnosis and Treatment

Progressive Multiple Sclerosis

Multiple Sclerosis and Related Disorders: Handbook of Clinical Neurology: Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab): ... (Handbook of Clinical Neurology, Volume 122)

Inflammatory Disorders of the Nervous System: Pathogenesis, Immunology, and Clinical Management (Current Clinical Neurology)

Neurologic Disease: A Modern Pathophysiologic Approach to Diagnosis and Treatment

Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology)

Springer - Schwann Cell Development and Pathology Book

Handbook of Multiple Sclerosis